General Info

  1. April 18, 2024

    Podcast: Clearing the air on compounding GLP1 drugs

    The whole issue of compounding GLP-1 agonists like semaglutide is fraught with land mines and misinformation — disinformation, even.

    It's good, then, that the Game Changers Pharmacotherapy Podcast had a couple of guests who know what they're talking about to clear some of the air: Tenille Davis, PharmD, RPh (chief advocacy officer for the Alliance for Pharmacy Compounding) and Scott Brunner, CAE (CEO of APC). The host — Geoff Wall, PharmD — has the chops, too; he's a professor of pharmacy practice at Drake University.

    It covers everything you need to know about compounding GLP-1s, including access, cost, and how shortages come into play. Even better, you might be able to get a half-hour of CPE credit, too!

    Check out "Compounded GLP1s" on the Game Changers podcast — click here or check your favorite podcast app.

    Read More
  2. April 15, 2024

    Revelation Pharma Appoints Brad Leach as Senior Vice President of 503B

    Tampa, FL - April 15, 2024- Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies dedicated to delivering innovative, high quality, and customized medications and services, proudly announces Brad Leach as their new Senior Vice President, 503B.

    With over three decades of acute care experience, including more than 25 years dedicated to the compounding pharmacy industry, Mr. Leach brings a wealth of knowledge garnered from Fortune 500 healthcare corporations to PE-backed organizations. His extensive expertise has been honed through adept navigation of regulatory shifts, evolving from pre-797 regulations to today’s dynamic 503B market landscape.

    Recognized for driving commercial growth and operational excellence, Mr. Leach boasts a proven track record of effectively building and leading teams to success. His multifaceted skill set spans business strategy, marketing, customer service, and new product development.

    Prior to joining Revelation Pharma,

    Read More
  3. March 29, 2024

    Proud to be Certified™ by Great Place To Work®

    FOR IMMEDIATE RELEASE

    REVELATION PHARMA Attains Prestigious Great Place To Work Certification™ for 2024-2025 

    Castle Rock, Colorado – March 29, 2024 – Revelation Pharma is thrilled to announce its official certification as a Great Place To Work® for the 2024-2025 period. This esteemed recognition marks the culmination of dedicated efforts and reflects the unwavering commitment of every member of the Revelation team to foster a positive and supportive workplace environment.

    As stated by Susann Caputo, Senior Vice President of Human Resources at Revelation Pharma, "Achieving certification as a Great Place to Work is a significant accomplishment that reflects the dedication and efforts of every member of our team. It's a validation of our commitment to creating a positive and supportive environment where every individual feels valued, empowered, and inspired to do their best work."

    The Great Place To Work Certification™ is awarded based entirely on feedback

    Read More
  4. March 26, 2024

    Kasra Moaddel Joins Revelation Pharma

    FOR IMMEDIATE RELEASE

    Kasra Moaddel Joins Revelation Pharma as Vice President of Corporate Development

    Tampa, FL - Revelation Pharma proudly welcomes Kasra Moaddel as the newest addition to its leadership team, assuming the role of Vice President of Corporate Development. With a stellar background in mergers & acquisitions (M&A) and corporate development, Moaddel brings a wealth of experience and strategic insight to drive Revelation Pharma's growth and expansion initiatives.

    Throughout his distinguished career, Moaddel has made significant contributions to esteemed healthcare entities, leaving a lasting impact on the industry. Particularly noteworthy is his instrumental role in shaping the corporate development and strategy of a prominent healthcare organization in Southern California. His strategic foresight and leadership played a pivotal role in establishing the organization as a key player in the region's healthcare scene.

    Read More
Page